Suntrust Banks’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-9,198
| Closed | -$1.08M | – | 1225 |
|
|
2017
Q3 | $1.08M | Buy |
9,198
+5,178
| +129% | +$609K | 0.01% | 709 |
|
|
2017
Q2 | $321K | Buy |
+4,020
| New | +$321K | ﹤0.01% | 1014 |
|
|
2014
Q4 | – | Sell |
-3,714
| Closed | -$290K | – | 1171 |
|
|
2014
Q3 | $290K | Sell |
3,714
-146
| -4% | -$11.4K | ﹤0.01% | 1179 |
|
|
2014
Q2 | $243K | Sell |
3,860
-1,624
| -30% | -$102K | ﹤0.01% | 1292 |
|
|
2014
Q1 | $367K | Buy |
5,484
+1
| +0% | +$67 | ﹤0.01% | 1483 |
|
|
2013
Q4 | $352K | Buy |
5,483
+2
| +0% | +$128 | ﹤0.01% | 1441 |
|
|
2013
Q3 | $350K | Buy |
+5,481
| New | +$350K | ﹤0.01% | 1406 |
|